Clinical Trial Update: The Effect Of E2007 On Pharmacodynamic Responses To Levodopa Among Patients With Parkinson's Disease Who Experience Dyskinesia And Motor Fluctuations [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating E2007 to alter pharmacodynamic responses to Levodopa in patients with Parkinson's disease and dyskinesia/motor fluctuations …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• E2007
• levodopa (levodopa)

Snippet

Sponsor: Eisai Inc. | Conditions: Parkinson's Disease | Phase 2 | Status: WITHDRAWN